TOYO (TOYO) Q1 2026 earnings review
Record Profitability as U.S. Manufacturing Scale-Up Accelerates
TOYO delivered an exceptionally strong Q1 2026, driven by the successful ramp of its 4GW Ethiopian cell facility and Houston module plant. Revenue accelerated 177% YoY to $142.8M, completely reversing last year's losses to post a robust $28.4M net income. The standout metric is gross margin, which skyrocketed to 33.5% (up from 9.3% a year ago), proving that shifting product mix to the high-ASP U.S. market is highly lucrative. While management reaffirmed FY26 adjusted net income guidance of $90-100M, the Q1 results suggest this target may be conservative. The company's 'Made in America' pivot is working, though the model remains heavily reliant on favorable U.S. trade policies.
🐂 Bull Case
Gross margin expanded to 33.5% as the company successfully matched low-cost Ethiopian cell production with high-margin U.S. module sales. This structural advantage gives TOYO massive operating leverage.
Current financial results and FY26 guidance completely exclude the potential impact of U.S. 45X manufacturing credits ($0.07/watt) for the Houston facility, presenting a significant unpriced tailwind.
🐻 Bear Case
Total operating expenses nearly doubled to $11.5M YoY. Sustained volume is strictly required to prevent these fixed costs from severely compressing margins if demand softens.
The entire business model relies on the U.S. maintaining elevated tariffs on competing Asian solar imports. Any unexpected relaxation of trade barriers would immediately threaten TOYO's domestic pricing power.
⚖️ Verdict: 🟢
Bullish. TOYO's aggressive vertical integration and geographic pivot are translating directly to the bottom line. Generating $48M in Adjusted EBITDA in a single quarter proves the viability of their US-focused strategy.
Key Themes
Structural Gross Margin Expansion
Accelerating. The most critical driver of Q1's success was the gross margin expanding to 33.5%, up from just 9.3% in 25Q1 and 16.6% in 25Q2. This was achieved through economies of scale at the Ethiopian facility and higher average selling prices from the Houston module plant. The company has successfully transitioned from a low-margin third-party seller to a high-margin vertically integrated US supplier.
Free Cash Flow Inflection
Reversing. TOYO generated $33.4M in operating cash flow in Q1, up almost 10x from $3.7M a year ago. Simultaneously, CapEx dropped to $4.6M (down from $16.0M in 25Q1) as the heavy lifting for the 4GW Ethiopian plant concluded. This cash generation flexibility is critical for funding the upcoming U.S. domestic cell plant without diluting shareholders.
Narrative Contradiction: 'Disciplined' OpEx Under Pressure
Management's press release cited 'disciplined operating expense management' as a driver for Adjusted EBITDA, yet the data contradicts this: General & Administrative expenses surged 69% YoY to $9.5M, and Selling & Marketing quadrupled to $2.0M. While covered by massive gross profit this quarter, this cost inflation represents a significant fixed burden if revenues stall.
Pivot to AI Economy R&D
Management announced plans to establish a U.S. R&D center specifically aimed at developing next-generation technologies to meet 'surging demand for on- and off-grid electricity to power the AI economy.' This is a strategic shift to attach the company's solar module output to the hyper-growth data center narrative.
Execution Risk on Domestic Cell Manufacturing
While the Houston module plant is ramping, management reiterated plans for a domestic U.S. cell plant. Cell manufacturing is significantly more capital intensive and operationally complex than module assembly. With $72M in current cash, attempting to build a U.S. cell plant could quickly exhaust liquidity and require external debt or equity financing.
Macro Picture: Regulatory Dependency
TOYO's entire margin premium is built on navigating the U.S. tariff environment (avoiding UFLPA and AD/CVD duties by producing cells in Ethiopia). The upcoming U.S. political cycle and any potential shifts in solar import tariffs remain an existential macro risk to their pricing power.
Other KPIs
Accelerating. Up from just $2.8M in 25Q1. The $45.5M YoY increase outpaced the gross profit increase, highlighting massive operating leverage despite the rising G&A costs.
Stable. Up from $58.9M sequentially (end of 25Q4). The liquidity position provides a moderate buffer, but will be tested as the company plans aggressive capital expenditures for the domestic U.S. cell facility.
Guidance
Stable. The company reaffirmed this guidance. However, having generated $28.4M in GAAP net income in Q1 alone, achieving a $95M midpoint implies roughly $22M per quarter for the rest of the year. This suggests guidance is either highly conservative or management expects some margin compression/CapEx drag in the back half of the year.
Accelerating. Reaffirmed. This represents strong growth compared to the ~4.2 GW targeted in FY25, supported fully by the Ethiopian facility running at its expanded 4 GW capacity alongside international output.
Accelerating. Reaffirmed. Demonstrates the expected scale-up of the Houston facility (which shipped ~250 MW in FY25). Securing module off-take ensures vertical margin capture on at least 20% of their total cell production.
Key Questions
Conservative Net Income Guidance?
With Q1 Net Income already at $28.4 million, your FY26 Adjusted Net Income guidance of $90-$100 million implies lower quarterly earnings for the rest of the year. What headwinds or cost increases are baked into the back half of 2026?
Capital Requirements for U.S. Cell Plant
You highlighted moving forward with a U.S. domestic cell plant. What is the estimated CapEx for this facility, and do you expect current cash flows to fully fund it, or will you require outside capital?
45X Manufacturing Credits Timeline
Since 45X credits are excluded from the current guidance, what is the regulatory or operational timeline for recognizing these credits on the P&L from the Houston module facility?
JINKO Litigation Update
Can you provide an update on the ongoing JINKO patent infringement lawsuits in California and Texas, and whether any potential legal costs or operational disruptions have been factored into the 2026 outlook?